Curevac to present at the society for immunotherapy of cancer (sitc) 39th annual meeting

TÜbingen, germany and boston, ma / accesswire / october 28, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced poster presentations at the society for immunotherapy of cancer (sitc) 39th annual meeting, taking place november 8-10 in houston, usa.
CVAC Ratings Summary
CVAC Quant Ranking